Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390

Julien Bezin^{1

2}, Clément Mathieu², Jean-Luc Faillie^{3

4}, Antoine Pariente^{1

2}

Affiliations

¹ 1Service de Pharmacologie, Pôle de Santé Publique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
² 2Pharmacoepidemiology Team, UMR 1219 Bordeaux Population Health Research Center, INSERM, University of Bordeaux, Bordeaux, France.
³ 3Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
⁴ 4Desbrest Institute of Epidemiology and Public Health, University of Montpellier, INSERM, Montpellier, France.

Comment

Julien Bezin et al. Diabetes Care. 2023.

. 2023 May 1;46(5):e121-e122.

doi: 10.2337/dci23-0016.

Julien Bezin^{1

2}, Clément Mathieu², Jean-Luc Faillie^{3

4}, Antoine Pariente^{1

2}

¹ 1Service de Pharmacologie, Pôle de Santé Publique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
² 2Pharmacoepidemiology Team, UMR 1219 Bordeaux Population Health Research Center, INSERM, University of Bordeaux, Bordeaux, France.
³ 3Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
⁴ 4Desbrest Institute of Epidemiology and Public Health, University of Montpellier, INSERM, Montpellier, France.

No abstract available

Comment on

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.
Bezin J, Gouverneur A, Pénichon M, Mathieu C, Garrel R, Hillaire-Buys D, Pariente A, Faillie JL. Bezin J, et al. Diabetes Care. 2023 Feb 1;46(2):384-390. doi: 10.2337/dc22-1148. Diabetes Care. 2023. PMID: 36356111
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
Goldenberg RM, Jain AB. Goldenberg RM, et al. Diabetes Care. 2023 May 1;46(5):e117. doi: 10.2337/dc22-2300. Diabetes Care. 2023. PMID: 37185678 No abstract available.
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
Endo M, Roth MY, Tylee TS, DeSantis A, Hirsch IB. Endo M, et al. Diabetes Care. 2023 May 1;46(5):e118. doi: 10.2337/dc22-2454. Diabetes Care. 2023. PMID: 37185687 No abstract available.
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
Smits MM, van Raalte DH. Smits MM, et al. Diabetes Care. 2023 May 1;46(5):e120. doi: 10.2337/dc23-0134. Diabetes Care. 2023. PMID: 37185688 No abstract available.
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
Mañas-Martinez AB, Gimeno-Orna JA. Mañas-Martinez AB, et al. Diabetes Care. 2023 May 1;46(5):e119. doi: 10.2337/dc23-0076. Diabetes Care. 2023. PMID: 37185691 No abstract available.